• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Call for evidence mapping in accordance with the changing features of invasive pulmonary aspergillosis during the coronavirus disease 2019 pandemic.呼吁根据2019冠状病毒病大流行期间侵袭性肺曲霉病的变化特征进行证据图谱分析。
Korean J Intern Med. 2022 Jul;37(4):742-744. doi: 10.3904/kjim.2022.199. Epub 2022 Jun 28.
2
Tendency in Pulmonary Aspergillosis Investigation during the COVID-19 Era: What Is Changing?COVID-19 时代肺部曲霉菌病研究趋势：有何变化？
Int J Environ Res Public Health. 2022 Jun 9;19(12):7079. doi: 10.3390/ijerph19127079.
3
Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series.中国浙江新冠肺炎患者侵袭性肺曲霉病的临床特征：一项回顾性病例系列研究
Crit Care. 2020 Jun 5;24(1):299. doi: 10.1186/s13054-020-03046-7.
4
COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges.新型冠状病毒肺炎相关肺曲霉病：发病率的地区差异及诊断挑战
Intensive Care Med. 2021 Nov;47(11):1339-1340. doi: 10.1007/s00134-021-06510-2. Epub 2021 Sep 1.
5
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.2019冠状病毒病危重症患者肺曲霉病的危险因素及预后——欧洲医学真菌学联合会的一项多国观察性研究
Clin Microbiol Infect. 2022 Apr;28(4):580-587. doi: 10.1016/j.cmi.2021.08.014. Epub 2021 Aug 26.
6
Implementation of a diagnostic algorithm for COVID-19-associated pulmonary aspergillosis.新型冠状病毒肺炎相关肺曲霉病诊断算法的实施
J Hosp Infect. 2022 Nov;129:203-206. doi: 10.1016/j.jhin.2022.07.023. Epub 2022 Aug 5.
7
COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.深圳市一家三级保健中心的 COVID-19 相关肺曲霉病。
J Infect Public Health. 2022 Feb;15(2):222-227. doi: 10.1016/j.jiph.2021.12.015. Epub 2022 Jan 6.
8
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.COVID-19 气管插管患者侵袭性肺曲霉病的流行病学：一项前瞻性研究。
Clin Infect Dis. 2021 Dec 6;73(11):e3606-e3614. doi: 10.1093/cid/ciaa1065.
9
Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.危重症 2019 冠状病毒病（COVID-19）相关肺曲霉病的危险因素：一项全国性、多中心、回顾性队列研究。
J Korean Med Sci. 2022 May 9;37(18):e134. doi: 10.3346/jkms.2022.37.e134.
10
[Aspergillus-related respiratory conditions and COPD: Diagnostic challenges].[曲霉相关的呼吸道疾病与慢性阻塞性肺疾病：诊断挑战]
Rev Mal Respir. 2020 Apr;37(4):308-319. doi: 10.1016/j.rmr.2020.02.011. Epub 2020 Apr 10.

引用本文的文献

1
High-Dose Corticosteroid Use in Severe to Critically Ill Patients With COVID-19: A Nationwide Population-Based Matched Cohort Study.COVID-19 重症至危重症患者中使用大剂量皮质类固醇：一项全国范围内基于人群的匹配队列研究。
J Korean Med Sci. 2024 Sep 2;39(34):e255. doi: 10.3346/jkms.2024.39.e255.

本文引用的文献

1
Risk factors and clinical impact of COVID-19-associated pulmonary aspergillosis: Multicenter retrospective cohort study.COVID-19 相关肺曲霉病的危险因素和临床影响：多中心回顾性队列研究。
Korean J Intern Med. 2022 Jul;37(4):851-863. doi: 10.3904/kjim.2022.069. Epub 2022 May 26.
2
Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.危重症 2019 冠状病毒病（COVID-19）相关肺曲霉病的危险因素：一项全国性、多中心、回顾性队列研究。
J Korean Med Sci. 2022 May 9;37(18):e134. doi: 10.3346/jkms.2022.37.e134.
3
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions.新型冠状病毒肺炎相关肺曲霉病的患病率：批判性综述与结论
J Fungi (Basel). 2022 Apr 12;8(4):390. doi: 10.3390/jof8040390.
4
COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients.COVID-19 相关肺曲霉病（CAPA）：危重症 COVID-19 患者的危险因素和预测评分的制定。
Mycoses. 2022 May;65(5):541-550. doi: 10.1111/myc.13434. Epub 2022 Mar 15.
5
Defining COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis.定义 COVID-19 相关肺曲霉病：系统评价和荟萃分析。
Clin Microbiol Infect. 2022 Jul;28(7):920-927. doi: 10.1016/j.cmi.2022.01.027. Epub 2022 Feb 10.
6
Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients.皮质类固醇类药物是重症监护患者 COVID-19 相关肺曲霉病的危险因素。
Crit Care. 2022 Jan 28;26(1):30. doi: 10.1186/s13054-022-03902-8.
7
Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?联合应用真菌学标准：能否更好地确定 COVID-19 相关肺曲霉病患者并评估预后？
J Clin Microbiol. 2022 Mar 16;60(3):e0216921. doi: 10.1128/JCM.02169-21. Epub 2022 Jan 5.
8
Pathogenesis of Respiratory Viral and Fungal Coinfections.呼吸道病毒和真菌合并感染的发病机制。
Clin Microbiol Rev. 2022 Jan 19;35(1):e0009421. doi: 10.1128/CMR.00094-21. Epub 2021 Nov 17.
9
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.应对 COVID-19 相关曲霉病的不确定性：与流感相关曲霉病的比较。
J Infect Dis. 2021 Nov 22;224(10):1631-1640. doi: 10.1093/infdis/jiab163.

Call for evidence mapping in accordance with the changing features of invasive pulmonary aspergillosis during the coronavirus disease 2019 pandemic.

作者信息

Yoon Young Kyung

机构信息

Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.

出版信息

Korean J Intern Med. 2022 Jul;37(4):742-744. doi: 10.3904/kjim.2022.199. Epub 2022 Jun 28.

DOI:10.3904/kjim.2022.199
PMID:35811364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9271729/
Abstract
摘要